Results 181 to 190 of about 457,723 (363)
The Cost Barrier to Renal Replacement Therapy and Peritoneal Dialysis in the Developing World [PDF]
Ricardo Correa‐Rotter
openalex +1 more source
Continuous Renal Replacement Therapy: Who, When, Why, and How
S. Tandukar, P. Palevsky
semanticscholar +1 more source
Wearable Bioelectronics for Home‐Based Monitoring and Treatment of Muscle Atrophy
As an inevitable disease, muscle atrophy has received more attention. Because the factors that induce this disease are diverse, achieving a complete cure is still impossible. Wearable bioelectronics provides a more comfortable, low‐cost, and efficient way of home care for the monitoring and treatment of muscle atrophy. Therefore, this review summarizes
Shuai Zhang+4 more
wiley +1 more source
Population pharmacokinetics of teicoplanin and dosage optimization in sepsis patients based on continuous renal replacement therapy. [PDF]
Sun Q+7 more
europepmc +1 more source
Outcome of renal replacement therapy in the very elderly [PDF]
K. Schaefer, D. von Herrath, B. Röhrich
openalex +1 more source
A novel copper silicate nanozyme (CSHSs‐Ar) with high peroxidase‐like catalytic activity and great catalytic specificity is well developed using a facile in situ valence‐engineered approach. The well‐developed CSHSs‐Ar nanozyme‐involved system can be utilized and employed as an efficient colorimetric sensor for the detection of volatile sulfur ...
Xiaocan Liu+9 more
wiley +1 more source
Renal replacement therapy in an intensive care unit: guidelines from the SRLF-GFRUP consensus conference. [PDF]
Jourdain M+19 more
europepmc +1 more source
Haemodialysis renal replacement therapy—do we need more research? [PDF]
Nathan W. Levin, Claudio Ronco
openalex +1 more source
Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment
A multifunctional GelMA cryogel enables dendritic cell immunotherapy that synergizes with doxorubicin and PD‐1 blockade, driving robust post‐surgical T‐cell immunity and suppressing TNBC recurrence. Abstract Triple‐negative breast cancer (TNBC) is an aggressive malignancy with high mortality and limited treatment options.
Lam‐Duc‐Huy Nguyen+7 more
wiley +1 more source